Home / Stocks / CGEM

CGEM insider trading

Cullinan Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$13.3M
Buys · last 90 days
0 · $0
Most recent buy
2025-10-30

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-10-30Lynx1 Capital Management LP
10% owner
Bought165,667$8.40$1.4M
2025-10-21Lynx1 Capital Management LP
10% owner
Bought248,749$8.46$2.1M
2025-10-10Lynx1 Capital Management LP
10% owner
Bought1,459,641$6.73$9.8M

Most active insider buyers

InsiderRoleBuysTotal bought
Lynx1 Capital Management LP10% owner3$13.3M

See CGEM on the chart

Every insider buy and sell for CGEM plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.